Showing 1 to 8 of 8 results


EU Considers Aggressive Retaliation Against Trump's Tariffs
Belgian Foreign Minister Maxime Prévot urges the European Union to respond forcefully to President Trump's tariffs by targeting the U.S. digital sector and potentially using its anti-coercion instrument, highlighting divisions within the EU over this strategy and the broader implications for transat...
EU Considers Aggressive Retaliation Against Trump's Tariffs
Belgian Foreign Minister Maxime Prévot urges the European Union to respond forcefully to President Trump's tariffs by targeting the U.S. digital sector and potentially using its anti-coercion instrument, highlighting divisions within the EU over this strategy and the broader implications for transat...
Progress
52% Bias Score


EU's Critical Medicines Act: 'Buy European' Policy Risks Trade Disputes
The European Commission's Critical Medicines Act, unveiled this week, aims to enhance the EU's medicine supply security by prioritizing EU manufacturing in public procurement and increasing domestic production, but faces funding constraints and lacks a coordinated contingency stockpiling plan.
EU's Critical Medicines Act: 'Buy European' Policy Risks Trade Disputes
The European Commission's Critical Medicines Act, unveiled this week, aims to enhance the EU's medicine supply security by prioritizing EU manufacturing in public procurement and increasing domestic production, but faces funding constraints and lacks a coordinated contingency stockpiling plan.
Progress
48% Bias Score


EU's Critical Medicines Act: "Buy European" Policy and Funding Concerns
The European Commission's proposed Critical Medicines Act aims to improve essential medicine supply within the EU, using a "Buy European" principle and increased domestic production but facing limited funding (€83 million for 2026-2027) and a lack of emergency stockpile coordination.
EU's Critical Medicines Act: "Buy European" Policy and Funding Concerns
The European Commission's proposed Critical Medicines Act aims to improve essential medicine supply within the EU, using a "Buy European" principle and increased domestic production but facing limited funding (€83 million for 2026-2027) and a lack of emergency stockpile coordination.
Progress
48% Bias Score


EU Proposes "Buy European" Mechanism to Tackle Critical Medicine Shortages
The EU proposed a new critical medicines act to address drug shortages, including a "Buy European" mechanism prioritizing supply security over price in public procurement, and a coordinated supply system for medicines of common interest, impacting supply chain resilience and access to essential drug...
EU Proposes "Buy European" Mechanism to Tackle Critical Medicine Shortages
The EU proposed a new critical medicines act to address drug shortages, including a "Buy European" mechanism prioritizing supply security over price in public procurement, and a coordinated supply system for medicines of common interest, impacting supply chain resilience and access to essential drug...
Progress
40% Bias Score

100+ European Firms Urge EU to Prioritize Homegrown Tech
Over 100 European companies, including Airbus and Dassault, are pushing the European Commission to prioritize homegrown technology in its digital infrastructure to reduce dependence on the U.S., citing worsening EU-U.S. relations and proposing a "Buy European" strategy and a sovereign infrastructure...

100+ European Firms Urge EU to Prioritize Homegrown Tech
Over 100 European companies, including Airbus and Dassault, are pushing the European Commission to prioritize homegrown technology in its digital infrastructure to reduce dependence on the U.S., citing worsening EU-U.S. relations and proposing a "Buy European" strategy and a sovereign infrastructure...
Progress
48% Bias Score

EU's Critical Medicines Act: 'Buy European' Clause and Funding Concerns
The European Commission's proposed Critical Medicines Act aims to improve EU medicine supply security through a 'Buy European' clause, new medicine categories, and improved joint procurement, but faces criticism for insufficient funding (€83 million for 2026-2027) and the lack of contingency stockpi...

EU's Critical Medicines Act: 'Buy European' Clause and Funding Concerns
The European Commission's proposed Critical Medicines Act aims to improve EU medicine supply security through a 'Buy European' clause, new medicine categories, and improved joint procurement, but faces criticism for insufficient funding (€83 million for 2026-2027) and the lack of contingency stockpi...
Progress
44% Bias Score

EU's Critical Medicines Act: Securing Drug Supply Amid Budgetary and Stockpiling Concerns
The European Commission unveiled its Critical Medicines Act, aiming to secure the EU's drug supply by prioritizing EU-based suppliers via a "Buy European" clause, promoting domestic production, and enhancing joint procurement mechanisms, but facing criticism over its limited budget and lack of emerg...

EU's Critical Medicines Act: Securing Drug Supply Amid Budgetary and Stockpiling Concerns
The European Commission unveiled its Critical Medicines Act, aiming to secure the EU's drug supply by prioritizing EU-based suppliers via a "Buy European" clause, promoting domestic production, and enhancing joint procurement mechanisms, but facing criticism over its limited budget and lack of emerg...
Progress
32% Bias Score

EU to Prioritize "Buy European" to Boost Green Industry and Counter Economic Nationalism
The European Commission will unveil a plan next week to promote "Buy European" policies to strengthen its climate-friendly industry, reduce reliance on global supply chains, and counter economic nationalism from China and the US, marking a significant departure from its previous globalist approach.

EU to Prioritize "Buy European" to Boost Green Industry and Counter Economic Nationalism
The European Commission will unveil a plan next week to promote "Buy European" policies to strengthen its climate-friendly industry, reduce reliance on global supply chains, and counter economic nationalism from China and the US, marking a significant departure from its previous globalist approach.
Progress
44% Bias Score
Showing 1 to 8 of 8 results